Sign In
Buy LYEL
$14.33
-0.680 (-4.53%)
At Close: Jul 13, 2026
3 Biotechs Plus a Mortgage Lender Go Public Today
12:36pm, Thursday, 17'th Jun 2021
The companies are Verve Therapeutics, Lyell Immunopharma, iSpecimen and Angel Oak Mortgage.
Lyell Immunopharma Announces Pricing of Initial Public Offering
09:49pm, Wednesday, 16'th Jun 2021
SOUTH SAN FRANCISCO, Calif., June 16, 2021 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Lyell), (Nasdaq: LYEL), a T cell reprogramming company dedicated to the mastery of T cells to cure patients wit
